Progesterone Agonist/Antagonist [EPC] - N0000191263

Pharmacologic Class Information

Pharmacologic Code N0000191263
Pharmacologic Name Progesterone Agonist/Antagonist
Pharmacologic Uses
  • progesterone agonist/antagonist
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Progesterone Agonist/Antagonist

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Progesterone Agonist/Antagonist [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
50090-5422Ella Non-Proprietary Name: Ulipristal AcetateTabletOralA-s Medication SolutionsACTIVE
53002-2630Ella Non-Proprietary Name: Ulipristal AcetateTabletOralRpk Pharmaceuticals, Inc.ACTIVE
67296-1466Ella Non-Proprietary Name: Ulipristal AcetateTabletOralRedpharm Drug, IncACTIVE
73302-456Ella Non-Proprietary Name: Ulipristal AcetateTabletOralHra Pharma America, Inc.ACTIVE